import MCQGroup from '@/components/MCQGroup'
import { Callout } from 'nextra/components'

# Bronchiectasis Overview

Bronchiectasis is a chronic condition characterized by the abnormal enlargement and inflammation of airways, leading to their potential collapse. This condition tends to be more prevalent with advancing age and is more common in women.

## Etiology and Pathophysiology

Bronchiectasis can develop due to a variety of factors, including:

- Infections
- Impaired immune response
- Structural airway conditions like tracheobronchomalacia
- Focal airway obstruction
- Smoking
- Genetic disorders, such as cystic fibrosis and primary ciliary dyskinesia

The pathophysiological mechanism typically involves an exaggerated neutrophilic inflammatory response to these triggers. This chronic inflammation results in the dilation and destruction of airway walls. Conditions like rheumatoid arthritis and Sjögren's syndrome can also lead to bronchiectasis, although the reasons behind these associations remain unclear.

## Clinical Features

Patients with bronchiectasis often exhibit:

- Persistent cough
- Daily production of purulent sputum, which becomes more viscous and darker during acute exacerbations
- Dyspnea
- Wheezing
- Chest pain

A history of recurrent respiratory infections is commonly reported in affected individuals.

## Diagnosis

### Clinical Assessment

Diagnosis begins with a clinical evaluation, emphasizing symptoms like a persistent productive cough. However, confirmation requires imaging evidence of airway dilatation.

### Imaging Studies

- **Chest X-ray (CXR):** May show non-specific signs such as atelectasis, “tram track” signs, and peripheral opacities.
  
- **Multidetector Computed Tomography (MDCT):** Critical for diagnosis, particularly when CXR is inconclusive. MDCT can reveal:
  - Bronchoarterial ratio > 1
  - Lack of bronchial tapering
  - Airway proximity to the costal or mediastinal pleura (< 1 cm or contact)

### Computed Tomography (CT) Distribution Patterns
CT findings can suggest underlying causes:

- Central or perihilar involvement: Allergic aspergillosis
- Upper lobe involvement: Cystic fibrosis
- Middle or lower lobe involvement: Primary ciliary dysfunction
- Lower lobe involvement: Idiopathic bronchiectasis

### Laboratory and Functional Testing

- **Laboratory Tests:**
  - Complete Blood Count (CBC)
  - Immunoelectrophoresis for immunodeficiencies
  - Cystic fibrosis tests (sweat test or mutation analysis)
  - Sputum culture for pathogen identification

- **Pulmonary Function Testing:**
  - Spirometry: May be normal or show an obstructive pattern in severe cases.

## Management

### Prescribing Strategies

The goals of bronchiectasis management include reducing inflammation and managing infections. Treatment options include:

- Hydration and mucolytic agents to aid in secretion clearance
- Antibiotics to decrease airway inflammation and bacterial load during acute exacerbations, tailored based on previous regimens, sputum analyses, and allergies
- Long-term antibiotics for recurrent exacerbations (>2-3 per year)

<Callout emoji="ℹ️">
**Tip:** When no sputum analysis is available, oral fluoroquinolones may be used. Treat resistant Pseudomonas with IV antibiotics in a hospital setting, based on sensitivity profiles.
</Callout>

### Non-Prescribing Interventions

- Addressing dysphagia or gastro-oesophageal reflux disease (GORD) to prevent aspiration
- Airway clearance therapies, including directed coughing and mechanical devices
- Surgical interventions for severe cases, such as lobectomy, lung transplant, or tracheobronchoplasty

### Preventative Therapies

- Nontuberculous mycobacteria (NTM) treatment
- Intravenous immunoglobulins (IVIG) for primary immunodeficiencies
- Glucocorticoids and antifungals for allergic bronchopulmonary aspergillosis

## References

- [UpToDate: Clinical manifestations and diagnosis of bronchiectasis in adults](https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-bronchiectasis-in-adults?search=bronchiectasis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1)
- [UpToDate: Clinical manifestations and diagnosis of bronchiectasis in adults](https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-bronchiectasis-in-adults?search=bronchiectasis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1)

---

<MCQGroup questions={[
  {
    question: "A 45-year-old male with a history of recurrent sinus infections and chronic productive cough presents with hemoptysis. A high-resolution CT scan demonstrates bronchiectasis predominantly in the upper lobes. Which of the following is the most likely underlying cause of his bronchiectasis?",
    options: [
      "Allergic bronchopulmonary aspergillosis",
      "Primary ciliary dyskinesia",
      "Cystic fibrosis",
      "Idiopathic causes",
      "Rheumatoid arthritis"
    ],
    correctAnswer: 0,
    correctFeedback: "Correct! The patient's history of recurrent sinus infections, chronic productive cough, and CT findings of upper lobe bronchiectasis suggest allergic bronchopulmonary aspergillosis as the most likely underlying cause.",
    incorrectFeedback: "Consider the distribution pattern of bronchiectasis on the CT scan and the patient's clinical history. Upper lobe involvement is characteristic of a specific underlying cause."
  },
  {
    question: "A 60-year-old woman with bronchiectasis has had three acute exacerbations requiring antibiotic therapy in the past year. Which of the following would be the most appropriate addition to her long-term management plan?",
    options: [
      "Initiation of daily oral corticosteroids",
      "Long-term antibiotic prophylaxis",
      "Lung transplant evaluation",
      "Surgical lobectomy",
      "Intensive immunoglobulin replacement therapy"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! Patients with bronchiectasis who experience frequent exacerbations (>2-3 per year) may benefit from long-term antibiotic prophylaxis to decrease airway inflammation and bacterial load.",
    incorrectFeedback: "Consider the frequency of the patient's exacerbations and the goals of bronchiectasis management in determining the most appropriate long-term management strategy."
  },
  {
    question: "During a pulmonary function test, a patient with bronchiectasis is likely to show which of the following patterns?",
    options: [
      "Restrictive pattern with reduced total lung capacity",
      "Obstructive pattern with a reduced FEV1/FVC ratio",
      "Normal spirometry",
      "A mixed obstructive-restrictive pattern",
      "Increased diffusion capacity for carbon monoxide (DLCO)"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! Spirometry in bronchiectasis may show an obstructive pattern with a reduced FEV1/FVC ratio, particularly in severe cases.",
    incorrectFeedback: "Revisit the pulmonary function testing section and consider the typical findings in patients with bronchiectasis."
  },
  {
    question: "Which of the following imaging findings is considered critical for the diagnosis of bronchiectasis?",
    options: [
      "Bronchoarterial ratio < 1 on MDCT",
      "Bronchial tapering on MDCT",
      "Airway proximity to the costal or mediastinal pleura < 1 cm on MDCT",
      "“Tram track” signs on CXR",
      "Peripheral opacities on CXR"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! A critical imaging finding for the diagnosis of bronchiectasis is airway proximity to the costal or mediastinal pleura < 1 cm or contact, as seen on MDCT.",
    incorrectFeedback: "Think about the specific imaging criteria needed to confirm the diagnosis of bronchiectasis. Which MDCT findings are diagnostic?"
  }
]} />